Sanofi Will Carve Out Consumer Health Division in Bid to Invest More in Science
The stand-alone division will be the latest addition to a growing list of such public companies recently spun out of larger drugmakers.
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The stand-alone division will be the latest addition to a growing list of such public companies recently spun out of larger drugmakers.
Investors concerned new obesity drugs could cut the need for invasive weight-loss procedures
Sanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a separately listed company based in France. The move could occur as soon as the fourth quarter of 2024, it said in astatement Friday.
Kenvue Inc.’s stock fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after...
In an attempt to facilitate a worldwide settlement, Johnson & Johnson is considering filing for bankruptcy a third time as it prepares for at least 18 jury trials over the course of the upcoming year related to allegations of tainted talc in its well-known baby powder. Between November and December 2024, J&J has talc cases scheduled for trial all over the country, from Pennsylvania to California.